.webp)
Ascertain, a healthcare AI company revolutionizing administrative workflows through agentic automation, has appointed Molly O'Neill as Chief Commercial Officer (CCO).
A nationally recognized healthcare leader with over 30 years of experience, O’Neill brings a proven record of driving growth, innovation, and strategic partnerships across health systems, startups, and global enterprises.
Before joining Ascertain, O’Neill served as Chief Strategic Partnerships Officer at Aegis Ventures, where she led the Digital Consortium, a pioneering venture studio model built in collaboration with more than 14 major health systems representing over US$100 billion in annual revenue. Her leadership in uniting healthcare providers, investors, and innovators has played a transformative role in advancing digital health collaboration at scale.
Previously, O’Neill served as Vice Chancellor for Duke Health, where she led strategic growth initiatives across clinical operations, education, and health innovation. Her extensive career also includes senior leadership roles at Medforth Global Healthcare Education Group, Tenet Healthcare, Mass General Brigham, Ascension Health Care Network, and Inova Health System.
At Ascertain, O’Neill will oversee the company’s commercial strategy and market development, guiding its mission to enhance efficiency and quality across healthcare’s administrative ecosystem.
Ascertain’s AI-driven automation platform has already demonstrated measurable success - achieving 67% faster prior authorization submissions and an 80% reduction in clicks per case across Northwell Health’s 28 hospitals.
Founded through a collaboration between Aegis Ventures and Northwell Health, Ascertain recently raised US$10 million in Series A funding led by Deerfield Management, marking a new phase of accelerated growth and industry impact.
